Other Barks & Bites for Friday, August 21: US Inventor Lacks Standing for Patent Language Challenge; D.C. Circuit Upholds CMS’ Single-Source Drug Interpretation; and Ninth Circuit Deepens Split on Attorney’s Fees Under Lanham Act

This week in Other Barks & Bites: the Fourth Circuit affirms an injunction against a scheme to divert Turkish-label versions of Biktarvy into the U.S. for sale; the Federal Circuit nixes US Inventor’s challenge to the “right to exclude others” language printed on issued U.S. patents; SK Biopharmaceutical agrees to allow generic Xcopri to enter the U.S. market by 2032; and more. The post Other Barks & Bites for Friday, August 21: US Inventor Lacks Standing for Patent Language Challenge;